Chromsystems Industry Workshop

Session Title:
Drugs Screening in Urine Using a Novel Fully Validated LCMS Assay

Presenters:
Huda Cathum, Chromsystems Instruments & Chemicals GmbH
Joseph Macri, Clinical Pathology, Hamilton General Hospital
Matthew Nichols, McMaster University, Molecular Genetics and Pediatric

Objectives:
At the conclusion of this session, participants will be able to:
1. Our goal is to explain how this Health Canada-approved new assay for the screening and simultaneous quantitation of 108 drugs/metabolites in urine can help clinical laboratories. Special focus will be placed on why and how a commercial assay can provide superior and reliable results with the ultimate goal of exceptional patient care. Data will be compared with immunoassay and GC-MS-based methods. The performance characteristics are described and the quality and regulatory background will be discussed.

Question Title

* 1. Please rate the Session by circling the appropriate number:
Rating Scale:1 Strongly Disagree, 2 Disagree, 3 Neutral, 4 Agree, 5 Strongly Agree

  1 2 3 4 5
Sufficient time was allowed for audience participation/active learning
The facilities were satisfactory.
The session was free from commercial bias
Overall, I would rate this Symposium as excellent

Question Title

* 2. Please asses the Speaker by circling the appropriate number.
Rating Scale: 1 Poor, 2 Fair, 3 Good, 4 Very Good, 5 Outstanding
Huda Cathum, Chromsystems Instruments & Chemicals GmbH

  1 2 3 4 5
Clarity of
Met Stated Objectives
Balanced & Unbiased
Relevant to Practice Overall
Time for Active Learning

Question Title

* 3. Please asses the Speaker by circling the appropriate number.
Rating Scale: 1 Poor, 2 Fair, 3 Good, 4 Very Good, 5 Outstanding
Joseph Macri, Clinical Pathology, Hamilton General Hospital

  1 2 3 4 5
Clarity of
Met Stated Objectives
Balanced & Unbiased
Relevant to Practice Overall
Time for Active Learning

Question Title

* 4. Please asses the Speaker by circling the appropriate number.
Rating Scale: 1 Poor, 2 Fair, 3 Good, 4 Very Good, 5 Outstanding
Matthew Nichols, McMaster University, Molecular Genetics and Pediatric

  1 2 3 4 5
Clarity of
Met Stated Objectives
Balanced & Unbiased
Relevant to Practice Overall
Time for Active Learning

Question Title

* 5. As a result of attending this session, I am planning to: (please check one)

  YES NO
a) Discuss the session with my colleagues
b) Pursue additional learning activities.
c) Complete a Personal Learning Project.
d) Not change my practice.
e) Change my practice.

Question Title

* 6. Please explain the change you are planning to make or the learning you plan to complete:

Question Title

* 7. Please indicate which CanMEDS roles you felt were addressed during this educational activity. (Select all that apply)

Question Title

* 8. General comments about individual speakers

Question Title

* 9. What topics need to be addressed at future conferences to keep you up to date in your profession?

T